Cargando…

Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study

BACKGROUND: In 2011, the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) published guidelines for the metabolic monitoring of antipsychotic-treated children and youth. Population-based studies examining adherence to these guidelines are needed to ensu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoniou, Tony, Wang, Tianru, Pajer, Kathleen, Gardner, William, Lunsky, Yona, Penner, Melanie, Tadrous, Mina, Mamdani, Muhammad, Juurlink, David N., Gomes, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217777/ https://www.ncbi.nlm.nih.gov/pubmed/37252150 http://dx.doi.org/10.3389/fpsyt.2023.1172559

Ejemplares similares

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017)

Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2019)

Varenicline and Risk of Self-Harm: A Nested Case-Control Study
por: Tadrous, Mina, et al.
Publicado: (2016)

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
por: Antoniou, Tony, et al.
Publicado: (2022)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)

Impact of Antipsychotic Guidelines on Laboratory Monitoring in Children with Neurodevelopmental Disorders
por: Kara, Imaan, et al.
Publicado: (2021)

The Burden of Opioid-Related Mortality in the United States
por: Gomes, Tara, et al.
Publicado: (2018)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

Trends in Opioid Toxicity–Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021
por: Gomes, Tara, et al.
Publicado: (2023)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
por: Piszczek, Jolanta, et al.
Publicado: (2014)

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study
por: Verma, Amol A., et al.
Publicado: (2018)

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
por: Tadrous, Mina, et al.
Publicado: (2021)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
por: Stephenson, J J, et al.
Publicado: (2012)

Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States
por: Zhang, Chengchen, et al.
Publicado: (2021)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Statins and the Risk of Herpes Zoster: A Population-Based Cohort Study
por: Antoniou, Tony, et al.
Publicado: (2014)

Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
por: Antoniou, Tony, et al.
Publicado: (2015)

The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization
por: Monson, Eric T., et al.
Publicado: (2023)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study
por: Tadrous, Mina, et al.
Publicado: (2018)

The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis
por: Boone, Charlotte G., et al.
Publicado: (2021)

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
por: Gomes, Tara, et al.
Publicado: (2022)

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
por: Fralick, Michael, et al.
Publicado: (2014)

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
por: Gomes, Tara, et al.
Publicado: (2017)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
por: Dinnissen, Mariken, et al.
Publicado: (2020)

New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada
por: Guan, Qi, et al.
Publicado: (2022)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls
por: Engelke, Rudolf, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dk2411g072h809fhg70rg17njv